Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Other Non Operating Income (2020 - 2025)

Roivant Sciences' Other Non Operating Income history spans 6 years, with the latest figure at $8.3 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 396.24% year-over-year to $8.3 million; the TTM value through Dec 2025 reached -$11.4 million, down 97.33%, while the annual FY2025 figure was -$10.7 million, 20.95% up from the prior year.
  • Other Non Operating Income reached $8.3 million in Q4 2025 per ROIV's latest filing, up from -$5.7 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $18.1 million in Q4 2022 to a low of -$11.2 million in Q2 2025.
  • Average Other Non Operating Income over 5 years is -$182066.7, with a median of -$1.5 million recorded in 2024.
  • The largest YoY upside for Other Non Operating Income was 1658.5% in 2022 against a maximum downside of 909.7% in 2022.
  • A 5-year view of Other Non Operating Income shows it stood at $1.0 million in 2021, then soared by 1658.5% to $18.1 million in 2022, then plummeted by 88.33% to $2.1 million in 2023, then tumbled by 233.33% to -$2.8 million in 2024, then skyrocketed by 396.24% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Other Non Operating Income are $8.3 million (Q4 2025), -$5.7 million (Q3 2025), and -$11.2 million (Q2 2025).